WHO ICTRP trial
Combination treatment with DDAVP and factor VIII clotting factor concentrates in…
EUCTR2014-005435-14-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2014-005435-14-NL |
|---|---|
| Public title | Combination treatment with DDAVP and factor VIII clotting factor concentrates in patients with mild haemophilia A. |
| Scientific title | DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild haemophilia A. - DAVID |
| Primary sponsor | Erasmus University Medical Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Netherlands |
| Conditions | Mild hemophilia A patients with a FVIII plasma levels above 0.05 IU/mL. MedDRA version: 18.1 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000004850 MedDRA version: 18.1 Level: LLT… |
| Interventions | Trade Name: Minrin Pharmaceutical Form: Solution for injection/infusion Trade Name: Octostim Pharmaceutical Form: Solution for injection/infusion Trade Name: Advate Pharmaceutical Form: Powder and solvent for solution for injection Trade… |
| Registration date | Oct 12, 2015 |
| Secondary IDs | 104616 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: